Options for intrauterine contraception

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 37, Issue 3, 2008, Pages 375-383

  Fantasia, Heidi Collins ^a,b,c  

^a Health Quarters   (United States)

^b BOSTON COLLEGE   (United States)

^c NONE   (United States)

Author keywords

Contraception; Copper T IUD; Family planning; Intrauterine devices; Levonorgestrel releasing IUS

Indexed keywords

EID: 44649190526     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/j.1552-6909.2008.00249.x     Document Type: Article

References (37)

1. American College of Obstetricians and Gynecologists. (2005). New cervical cancer screening guidelines: Doing the right thing. Retrieved September 16, 2007, from http://www.acog.org/acog_districts/ dist_notice.cfm?recno=1&bulletin=1698
2. Andersson, K., Batar, I., & Rybo, G. (1992). Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova T. Contraception, 46, 575-584.
3. Bracken, M. D., & Vita, A. (1983). Frequency of non-hormonal contraception around conception and association with congenital malformations in offspring. American Journal of Epidemiology, 117, 281-291.
4. Caliskan, E., Ozturk, N., Dilbaz, B. O., & Dilbaz, S. (2003). Analysis of risk factors associated with uterine perforation by intrauterine devices. European Journal of Contraception and Reproductive Health Care, 29, 227-231.
5. Curtis, K. M., Marchbanks, P. A., & Peterson, H. B. (2007). Neoplasia with use of intrauterine devices. Contraception, 75, S60-S69.
6. Dajani, A. S., Taubert, K. A., Wilson, W., Bolger, A. F., Bayer, A., Ferrier, P., et al. (1997). Prevention of bacterial endocarditis: Recommendations by the American Heart Association. Circulation, 96, 358-366.
7. Ellertson, C., Trussell, J., Stewart, F., Koening, J., Raymond, E. G., & Shochet, T. (2001). Emergency contraception. Seminars in Reproductive Medicine, 19, 323-330.
8. Farmer, M. (2003). Intrauterine device insertion-related complications: Can they be predicted? Journal of Family Planning and Reproductive Health Care, 29, 277-231.
9. Farquhar, C. M. (2005). Ectopic pregnancy. Lancet, 366, 583-591.
10. Finer, L. B., & Henshaw, S. K. (2006). Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspectives on Sexual and Reproductive Health, 38, 90-96.
11. Fraser, I. S. (2007). The promise and reality of the intrauterine route for hormone delivery for the prevention and therapy of gynecological disease. Contraception, 75, S112-S117.
12. Grimes, D. A. (2000). Intrauterine device and upper-genital-tract infection. Lancet, 356, 1013-1019.
13. Grimes, D. A. (2001). Intrauterine devices and infertility: Sifting through the evidence. Lancet, 358, 6-7.
14. Grimes, D. A., & Schulz, K. F. (1999). Prophylactic antibiotics for intrauterine device insertion: A metaanalysis of the randomized controlled trials. Contraception, 60, 57-63.
15. Grimes, D. A., Lopez, L. M., Manion, C., & Schultz, K. F. (2007). Cochrane systematic reviews of IUD trials: Lessons learned. Contraception, 75 (Supp. 1), S55-S59.
16. Guttinger, A., & Critchley, H. O. D. (2007). Endometrial effects of intrauterine levonorgestrel. Contraception, 75, S93-S98.
17. Hubacher, D. (2007). Copper intrauterine device use by nulliparous women: Review of side effects. Contraception, 75, S8-S11.
18. Hubacher, D., & Cheng, D. (2004). Intrauterine devices and reproductive health: American women in feast or famine. Contraception, 69, 437-446.
19. Hubacher, D., Lara-Ricalde, R., Taylor, D. J., Guerra-Infante, F., & Guzman-Rodriguez, R. (2001). Use of copper intrauterine devices and the risk of infertility among nulligravid women. New England Journal of Medicine, 345, 561-567.
20. Johnson, B. A. (2005). Insertion and removal of intrauterine devices. American Family Physician, 71, 95-102.
21. Meirik, O. (2007). Intrauterine devices-upper and lower genital tract infections. Contraception, 76, S41-S47.
22. Nelson, A. L. (2007). Contraindications to IUD and IUS use. Contraception, 75, S76-S81.
23. Peterson, H. B., & Curtis, K. M. (2005). Long-acting methods of contraception. New England Journal of Medicine, 353, 2169-2175.
24. Prager, S., & Darney, P. D. (2007). The levonorgestrel intrauterine system in nulliparous women. Contraception, 75, S12-S15.
25. Rosenblatt, R., Zakin, D., Stern, W. Z., & Kutcher, R. (1985). Uterine perforation and embedding by intrauterine device: Evaluation by US and hysterography. Radiology, 157, 765-770.
26. Sitruk-Ware, R. (2007). The levonorgestrel intrauterine system for use in peri- and postmenopausal women. Contraception, 75, S155-S160.
27. Sivin, I. (1991). Dose-and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstetrics and Gynecology, 78, 291-298.
28. Society of Obstetricians and Gynecologists of Canada. (2004). Canadian contraception consensus. SOGC Clinical Practice Guidelines, No. 143, 1-36.
29. Stanford, J. B., & Mikolajczyk, R. T. (2002). Mechanisms of action of intrauterine devices: Update and estimation of postfertilization effects. American Journal of Obstetrics and Gynecology, 187, 1699-1708.
30. Tatum, H. J., Schmidt, F. H., & Jain, A. K. (1976). Management and outcome of pregnancies associated with the copper T intrauterine contraceptive device. American Journal of Obstetrics and Gynecology, 126, 869-879.
31. Tatum, H. J., Schmidt, F. H., Phillips, D., McCarty, M., & O'Leary, W. M. (1975). The Dalkon Shield controversy: Structural and bacteriobiological studies of IUD tails. Journal of the American Medical Association, 231, 711-717.
32. Tone, A. (2001). Devices and desires: A history of contraceptives in America. New York: Hill and Wang.
33. Weinstock, H., Berman, S., & Cates, W. (2004). Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health, 36 (1), 6-10.
34. World Health Organization. (2004). Medical eligibility criteria for contraceptive use (3rd ed.). Retrieved June 1, 2007, from http://www.who.int/reproductive-health/publications/mec/mec.pdf
35. Wright, T., Massad, L., Dunston, C., Spitzer, M., Wilkinson, E., & Solomon, D. (2007). 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. American Journal of Obstetrics and Gynecology, 197, 346-355.
36. Wysocki, S., Moore, A., & Ramos, D. E. (2007). Intrauterine contraception: Who, why, and how. Clinical Advisor, 10 (8) (Suppl.), 3-18.
37. Zhou, L., Harrison-Woolrych, M., & Coulter, D. M. (2003). Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena). Pharmacoepidemiology and Drug Safety, 12, 371-377.